Mice Doubly-Deficient in Lysosomal Hexosaminidase A and Neuraminidase 4 Show Epileptic Crises and Rapid Neuronal Loss
Tay-Sachs disease is a severe lysosomal disorder caused by mutations in the HexA gene coding for the α-subunit of lysosomal β-hexosaminidase A, which converts GM2 to GM3 ganglioside. Hexa−/− mice, depleted of β-hexosaminidase A, remain asymptomatic to 1 year of age, because they catabolise GM2 ganglioside via a lysosomal sialidase into glycolipid GA2, which is further processed by β-hexosaminidase B to lactosyl-ceramide, thereby bypassing the β-hexosaminidase A defect. Since this bypass is not effective in humans, infantile Tay-Sachs disease is fatal in the first years of life. Previously, we identified a novel ganglioside metabolizing sialidase, Neu4, abundantly expressed in mouse brain neurons. Now we demonstrate that mice with targeted disruption of both Neu4 and Hexa genes (Neu4−/−;Hexa−/−) show epileptic seizures with 40% penetrance correlating with polyspike discharges on the cortical electrodes of the electroencephalogram. Single knockout Hexa−/− or Neu4−/− siblings do not show such symptoms. Further, double-knockout but not single-knockout mice have multiple degenerating neurons in the cortex and hippocampus and multiple layers of cortical neurons accumulating GM2 ganglioside. Together, our data suggest that the Neu4 block exacerbates the disease in Hexa−/− mice, indicating that Neu4 is a modifier gene in the mouse model of Tay-Sachs disease, reducing the disease severity through the metabolic bypass. However, while disease severity in the double mutant is increased, it is not profound suggesting that Neu4 is not the only sialidase contributing to the metabolic bypass in Hexa−/− mice.
Vyšlo v časopise:
Mice Doubly-Deficient in Lysosomal Hexosaminidase A and Neuraminidase 4 Show Epileptic Crises and Rapid Neuronal Loss. PLoS Genet 6(9): e32767. doi:10.1371/journal.pgen.1001118
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1001118
Souhrn
Tay-Sachs disease is a severe lysosomal disorder caused by mutations in the HexA gene coding for the α-subunit of lysosomal β-hexosaminidase A, which converts GM2 to GM3 ganglioside. Hexa−/− mice, depleted of β-hexosaminidase A, remain asymptomatic to 1 year of age, because they catabolise GM2 ganglioside via a lysosomal sialidase into glycolipid GA2, which is further processed by β-hexosaminidase B to lactosyl-ceramide, thereby bypassing the β-hexosaminidase A defect. Since this bypass is not effective in humans, infantile Tay-Sachs disease is fatal in the first years of life. Previously, we identified a novel ganglioside metabolizing sialidase, Neu4, abundantly expressed in mouse brain neurons. Now we demonstrate that mice with targeted disruption of both Neu4 and Hexa genes (Neu4−/−;Hexa−/−) show epileptic seizures with 40% penetrance correlating with polyspike discharges on the cortical electrodes of the electroencephalogram. Single knockout Hexa−/− or Neu4−/− siblings do not show such symptoms. Further, double-knockout but not single-knockout mice have multiple degenerating neurons in the cortex and hippocampus and multiple layers of cortical neurons accumulating GM2 ganglioside. Together, our data suggest that the Neu4 block exacerbates the disease in Hexa−/− mice, indicating that Neu4 is a modifier gene in the mouse model of Tay-Sachs disease, reducing the disease severity through the metabolic bypass. However, while disease severity in the double mutant is increased, it is not profound suggesting that Neu4 is not the only sialidase contributing to the metabolic bypass in Hexa−/− mice.
Zdroje
1. GravelRA
KabackMM
ProiaRL
SandhoffK
SuzukiK
2001 The GM2 Gangliosidoses.
ScriverCR
BeaudetAL
Sly WS, ValleD
The Metabolic and Molecular Basis of Inherited Disease New York McGraw-Hill 3827 3876
2. MeiklePJ
HopwoodJJ
ClagueAE
CareyWF
1999 Prevalence of lysosomal storage disorders. JAMA 281 249 254
3. KabackMM
RimoinDL
O'BrienJS
1977 Tay-Sachs Disease: Screening and Prevention. New York Alan R. Liss (pub.)
4. AndermannE
ScriverCR
WolfeLS
DanskyL
AndermannF
1977 Genetic variants of Tay-Sachs disease and Sandhoff's disease in French-Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population.
KabackMM
RimoinDL
O'BrienJS
Tay-Sachs Disease: Screening and Prevention New York Alan R. Liss (pub.) 161 168
5. SangoK
YamanakaS
HoffmannA
OkudaY
GrinbergA
1995 Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11 170 176
6. PhaneufD
WakamatsuN
HuangJQ
BorowskiA
PetersonAC
1996 Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 5 11 14
7. TaniikeM
YamanakaS
ProiaRL
LangamanC
Bone-TurrentineT
1995 Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease. Acta Neuropath 89 296 304
8. MiklyaevaEI
DongW
BureauA
FattahieR
XuY
2004 Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system. Brain Res. 1001 37 50
9. MartinoS
di GirolamoI
CavazzinC
TiribuziR
GalliR
2009 Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology. J Neurochem 109 135 147
10. SeyrantepeV
CanuelM
ZengJ
LandryK
LiangF
2008 Mice deficient in the Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage. Hum Mol Genet 17 1556 1568
11. SeyrantepeV
LandryK
TrudelS
HassanJA
MoralesCR
2004 Neu4, a novel human lysosomal lumen sialidase confers normal phenotype to sialidosis cells. J Biol Chem 279 37021 37029
12. ComelliEM
AmadoM
LustigSR
PaulsonJC
2003 Identification and expression of Neu4, a novel murine sialidase. Genetics 321 155 161
13. MontiE
BassiMT
BrescianiR
CiviniS
CrociGL
2004 Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family. Genomics 83 445 453
14. YamaguchiK
HataK
KosekiK
ShiozakiK
AkitaH
2005 Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J 390(Pt 1) 85 93
15. IrwinS
1966 Comprehensive observational assessment: A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia (Berl.) 13 222 257
16. NakamuraK
KoikeM
ShitaraK
KuwanaY
KiuragiK
1994 Chimeric anti-ganglioside GM2 antibody with antitumor activity. Cancer Res Mar 15;54 1511 1516
17. HuangJQ
TraslerJM
IgdouraS
MichaudJ
HanalN
1997 Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 6 1879 1885
18. FetissovSO
JacobyAS
BrumovskyPR
ShineJ
IismaaTP
2003 Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice. Epilepsia 44 1022 1033
19. BiW
YanJ
ShiX
Yuva-PaylorLA
AntalffyBA
2007 Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Hum Mol Genet 16 1802 1813
20. PshezhetskyAV
AshmarinaM
2001 Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology. Prog Nucleic Acid Res Mol Biol 69 81 114
21. HiraiwaM
NishizawaM
UdaY
NakajimaT
MiyatakeT
1988 Human placental sialidase: further purification and characterization. J Biochem 103 86 90
22. ManciniGM
HoogeveenAT
GaljaardH
ManssonJE
SvennerholmL
1986 Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency. Hum Genet 73 35 38
23. Ulrich-BottB
KlemB
KaiserR
SprangerJ
CantzM
1987 Lysosomal sialidase deficiency: increased ganglioside content in autopsy tissues of a sialidosis patient. Enzyme 38 262 266
24. HasegawaT
YamaguchiK
WadaT
TakedaA
ItoyamaY
2000 Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J Biol Chem 275 8007 8015
25. ZanchettiG
ColombiP
ManzoniM
AnastasiaL
CaimiL
2007 Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures. Biochem J 408 211 219
26. LemaPP
GirardC
VachonP
2004 Dexamethasone for the treatment of intracerebral hemorrhage using a collagenase-induced cerebral hematoma rat model. J Vet Pharmacol Therap 27 321 328
27. SavardC
LemaPP
HélieP
VachonP
2009 Evaluation of delayed dexamethasone treatment on the outcome of collagenase-induced intracerebral hemorrhage in rats. Comp Med 59 444 448
28. DeipolyiAR
FangS
PalopJJ
YuGQ
WangX
2008 Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice. Neurobiol Aging 29 253 266
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2010 Číslo 9
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
Najčítanejšie v tomto čísle
- Optimal Strategy for Competence Differentiation in Bacteria
- Synthesizing and Salvaging NAD: Lessons Learned from
- Long- and Short-Term Selective Forces on Malaria Parasite Genomes
- Identifying Signatures of Natural Selection in Tibetan and Andean Populations Using Dense Genome Scan Data